Single-Institute Review of HER-2/Neu-Positive Invasive Lobular Breast Carcinoma in an Arab Population

od Osmani, Asif Husain, Tulbah, Asma M., Alsayed, Adher, AlShanqeeti, Ali, Al-Twegieri, Taher, Ajarim, Dahish S., Suleman, Kausar
izdano v Am J Case Rep (2021)

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience

od Alshabanah Mohamed, Al Malik Osama, Tulbah Asma, Alsayed Adher, Al-Zahrani Ali, Ajarim Dahish, Dermime Said, Elkum Naser, Ezzat Adnan, Al-Tweigeri Taher
Izdano 2007-12-01

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience

od Elkum, Naser, Dermime, Said, Ajarim, Dahish, Al-Zahrani, Ali, Alsayed, Adher, Tulbah, Asma, Al Malik, Osama, Alshabanah, Mohamed, Ezzat, Adnan, Al-Tweigeri, Taher
Izdano 2007

Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs

od Suleman, Kausar, Mushtaq, Ali Hassan, Haque, Emaan, Badran, Ahmed Ali, Ajarim, Dahish, Elashwah, Ahmed Mohammed, Gad, Ahmed Mostafa, Abdelsamad, Amgad Shaheen, Omar, Ayman, Khan, Khurshid Ahmed, Al-Tweigeri, Taher, Elshentenawy, Ayman, Alsayed, Adher
izdano v Breast Care (Basel) (2021)